“…However, its properties and efficacy can vary widely with taxon, necessitating rigorous evaluation in the target species to demonstrate its effectiveness and justify its use (García‐Párraga et al, 2016; Lee et al, 2016; Nardini et al, 2014; Steeil et al, 2014; Sypniewski et al, 2017; Thuesen et al, 2009). Cefovecin use has been reported in a variety of non‐domestic felids—including caracals, tigers, lions, an ocelot, lynx, and bobcats—with minimal to no adverse effects reported (Bertelsen et al, 2010; DeFrancisco & Stern, 2013; Devesa‐Garcia et al, 2016; Marti et al, 2019; Mejia‐Fava et al, 2015; Sadler et al, 2016; Schrader et al, 2012; Silva et al, 2013; Steeil et al, 2012). In exotic felids, its uses have included conservative treatment of pyothorax, adjunctive therapy for septic peritonitis subsequent to pyometra, and post‐operative antimicrobial prophylaxis.…”